日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinically Important Improvements and Disease Stability with Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy in the ELLITHE Trial: A Post Hoc Responder Analysis

ELLITHE试验中,氟替卡松糠酸酯/乌美溴铵/维兰特罗每日一次单吸入器三联疗法可带来具有临床意义的改善和疾病稳定性:一项事后应答者分析

Beeh, Kai-Michael; Scheithe, Karl; Schmutzler, Heike; Krüger, Saskia

Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy for Symptomatic COPD: The ELLITHE Non-Interventional Trial

氟替卡松糠酸酯/乌美溴铵/维兰特罗每日一次单吸入器三联疗法治疗症状性慢性阻塞性肺疾病的真实世界疗效:ELLITHE 非干预性试验

Beeh, Kai-Michael; Scheithe, Karl; Schmutzler, Heike; Krüger, Saskia

Impact of a content-based image retrieval system on the interpretation of chest CTs of patients with diffuse parenchymal lung disease

基于内容的图像检索系统对弥漫性实质性肺疾病患者胸部CT图像解读的影响

Röhrich, Sebastian; Heidinger, Benedikt H; Prayer, Florian; Weber, Michael; Krenn, Markus; Zhang, Rui; Sufana, Julie; Scheithe, Jakob; Kanbur, Incifer; Korajac, Aida; Pötsch, Nina; Raudner, Marcus; Al-Mukhtar, Ali; Fueger, Barbara J; Milos, Ruxandra-Iulia; Scharitzer, Martina; Langs, Georg; Prosch, Helmut